Healthcare - Biotechnology - NASDAQ - US
$ 13.86
-9.41 %
$ 807 M
Market Cap
-5.39
P/E
Price Target
Average
123.67%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
22.00%
Net Income
Estimate
3.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cullinan Oncology, Inc.
Wall Street analysts predict an average 1-year price target for CGEM of $31 , with forecasts ranging from a low of $28 to a high of $38 .
CGEM Lowest Price Target
Wall Street Target
28 USD
102.02%
CGEM Average Price Target
Wall Street Target
31 USD
123.67%
CGEM Highest Price Target
Wall Street Target
38 USD
174.17%
REVENUE FORECAST
Revenue Forecast Chart CGEM
EBIT FORECAST
EBIT Forecast Chart CGEM
NET INCOME FORECAST
Net Income Chart CGEM